Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure

European Journal of Medical Research

HR Figulla²  D Barz¹  H Thude¹  M Fabris¹  C Jung²  F Lorenz¹  M Fritzenwanger² 

[1] Institute for Transfusion Medicine, Friedrich-Schiller-University, Jena, Germany;Department of Internal Medicine I, Friedrich-Schiller-University, Jena, Germany

关键词: progenitor cell;    congestive heart failure;    CD133;    CD34;   

Others  :  1093933
DOI  :  10.1186/2047-783X-14-3-113

 received in 2009-01-06, accepted in 2009-01-12,  发布年份 2009

【 摘 要 】

Background

Endothelial progenitor cells (EPC) which are characterised by the simulateous expression of CD34, CD133 and vascular endothelial growth receptor 2 (VEGF 2) are involved in the pathophysiology of congestive heart failure (CHF) and their number and function is reduced in CHF. But so far our knowledge about the number of circulating hematopoietic stem/progenitor cells (CPC) expressing the early hematopoietic marker CD133 and CD34 in CHF is spares and therefore we determined their number and correlated them with New York Heart Association (NYHA) functional class.

Methods

CD34 and CD133 surface expression was quantified by flow cytometry in the peripheral venous blood of 41 healthy adults and 101 patients with various degrees of CHF.

Results

CD34+, CD133+ and CD34+/CD133+ cells correlated inversely with age. Both the number of CD34+ and of CD34+/CD133+ cells inversely correlated with NYHA functional class. The number of CD133+ cells was not affected by NYHA class. Furthermore the number of CD133+ cells did not differ between control and CHF patients.

Conclusion

In CHF the release of CD34+, CD133+ and CD34+/CD133+ cells from the bone marrow seems to be regulated differently. Modulating the releasing process in CHF may be a tool in CHF treatment.

【 授权许可】

   
2009 I. Holzapfel Publishers

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]McMurray JJ, Pfeffer MA: Heart failure. Lancet 2005, 365(9474):1877-1889.
• [2]Khakoo AY, Finkel T: Endothelial progenitor cells. Annu Rev Med 2005, 56:79-101.
• [3]Agnoletti L, Curello S, Bachetti T, Malacarne F, Gaia G, Comini L, Volterrani M, Bonetti P, Parrinello G, Cadei M, Grigolato PG, Ferrari R: Serum from patients with severe heart failure downregulates eNOS and is proapoptotic: role of tumor necrosis factor-alpha. Circulation 1999, 100(19):1983-1991.
• [4]Andreou I, Tousoulis D, Tentolouris C, Antoniades C, Stefanadis C: Potential role of endothelial progenitor cells in the pathophysiology of heart failure: clinical implications and perspectives. Atherosclerosis 2006, 189(2):247-254. Epub 2006 Jul 24
• [5]Luttun A, Carmeliet G, Carmeliet P: Vascular progenitors: from biology to treatment. Trends Cardiovasc Med 2002, 12(2):88-96.
• [6]Szmitko PE, Fedak PW, Weisel RD, Stewart DJ, Kutryk MJ, Verma S: Endothelial progenitor cells: new hope for a broken heart. Circulation 2003, 107(24):3093-3100.
• [7]Prater DN, Case J, Ingram DA, Yoder MC: Working hypothesis to redefine endothelial progenitor cells. Leukemia 2007, 21:1141-1149.
• [8]Shaffer RG, Greene S, Arshi A, Supple G, Bantly A, Moore JS, Mohler ER: Flow cytometric measurement of circulating endothelial cells: the effect of age and peripheral arterial disease on baseline levels of mature and progenitor populations. Cytometry B Clin Cytom 2006, 70:56-62.
• [9]Scheubel RJ, Zorn H, Silber RE, Kuss O, Morawietz H, Holtz J, Simm A: Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 2003, 42(12):2073-2080.
• [10]Nonaka-Sarukawa M, Yamamoto K, Aoki H, Nishimura Y, Tomizawa H, Ichida M, Eizawa T, Muroi K, Ikeda U, Shimada K: Circulating endothelial progenitor cells in congestive heart failure. Int J Cardiol 2007, 119(3):344-348. Epub 2006 Oct 27
• [11]Theiss HD, David R, Engelmann MG, Barth A, Schotten K, Naebauer M, Reichart B, Steinbeck G, Franz WM: Circulation of CD34+ progenitor cell populations in patients with idiopathic dilated and ischaemic cardiomyopathy (DCM and ICM). Eur Heart J 2007, 28(10):1258-1264. Epub 2007 Mar 29
• [12]Valgimigli M, Rigolin GM, Fucili A, Porta MD, Soukhomovskaia O, Malagutti P, Bugli AM, Bragotti LZ, Francolini G, Mauro E, Castoldi G, Ferrari R: CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation 2004, 110(10):1209-1212. Epub 2004 Jul 12
• [13]Michowitz Y, Goldstein E, Wexler D, Sheps D, Keren G, George J: Circulating endothelial progenitor cells and clinical outcome in patients with congestive heart failure. Heart 2007, 93(9):1046-1050. Epub 2007 Feb 3
• [14]Schatteman G: Are circulating CD133+ cells biomarkers of vascular disease? Arterioscler Thromb Vasc Biol 2005, 25(2):270-271.
• [15]Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, Oz MC, Hicklin DJ, Witte L, Moore MA, Rafii S: Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000, 95(3):952-958.
• [16]Quirici N, Soligo D, Caneva L, Servida F, Bossolasco P, Deliliers GL: Differentiation and expansion of endothelial cells from human bone marrow CD133(+) cells. Br J Haematol 2001, 115(1):186-194.
• [17]Heeschen C, Lehmann R, Honold J, Assmus B, Aicher A, Walter DH, Martin H, Zeiher AM, Dimmeler S: Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 2004, 109(13):1615-1622. Epub 2004 Mar 22
• [18]Iversen PO, Woldbaek PR, Tønnessen T, Christensen G: Decreased hematopoiesis in bone marrow of mice with congestive heart failure. Am J Physiol Regul Integr Comp Physiol 2002, 282(1):R166-172.
• [19]Geft D, Schwartzenberg S, Rogowsky O, Finkelstein A, Ablin J, Maysel-Auslender S, Wexler D, Keren G, George J: Circulating apoptotic progenitor cells in patients with congestive heart failure. PLoS ONE 2008, 3(9):e3238.
• [20]Kissel CK, Lehmann R, Assmus B, Aicher A, Honold J, Fischer-Rasokat U, Heeschen C, Spyridopoulos I, Dimmeler S, Zeiher AM: Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure. J Am Coll Cardiol 2007, 49(24):2341-2349.